Quo Vadis Aspirin In Primary Prevention?

Jacopo D’Andria Ursoleo, Giuseppe Biondi-Zoccai, George W. Booz

Open source

DOI
10.1097/fjc.0000000000001865
Published
2026-07-28
Container
Journal of Cardiovascular Pharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/fjc.0000000000001865,
  title = {Quo Vadis Aspirin In Primary Prevention?},
  author = {Jacopo D’Andria Ursoleo and Giuseppe Biondi-Zoccai and George W. Booz},
  year = {2026},
  journal = {Journal of Cardiovascular Pharmacology},
  doi = {10.1097/fjc.0000000000001865},
  url = {https://doi.org/10.1097/fjc.0000000000001865}
}

RIS

TY  - JOUR
TI  - Quo Vadis Aspirin In Primary Prevention?
AU  - Jacopo D’Andria Ursoleo
AU  - Giuseppe Biondi-Zoccai
AU  - George W. Booz
PY  - 2026
JO  - Journal of Cardiovascular Pharmacology
DO  - 10.1097/fjc.0000000000001865
UR  - https://doi.org/10.1097/fjc.0000000000001865
ER  - 

APA

Ursoleo, J. D., Biondi-Zoccai, G., & Booz, G. W. (2026). Quo Vadis Aspirin In Primary Prevention?. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0000000000001865

Source records